Senior insider sale
Chief Executive Officer at 10X GENOMICS, INC. — senior position signals high conviction
$910.7K
41.15K shares
What this filing means
SAXONOV SERGE plans to sell 41.15K shares of 10X GENOMICS, INC. valued at approximately $910.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001968582-26-000191
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
41.15K
Shares to sell
$910.7K
Approx. market value
41.15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
RSU Vesting
Compensation
2/21/2026
16.15KRSU Vesting
Compensation
8/21/2024
4.98KRSU Vesting
Compensation
5/21/2024
8.16KRSU Vesting
Compensation
8/21/2023
3.72KRSU Vesting
Compensation
5/21/2023
4.88KRSU Vesting
Compensation
2/21/2023
3.27KTotal acquired41.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2026 | RSU Vesting Compensation | 16.15K | — |
8/21/2024 | RSU Vesting Compensation | 4.98K | — |
5/21/2024 | RSU Vesting Compensation | 8.16K | — |
8/21/2023 | RSU Vesting Compensation | 3.72K | — |
5/21/2023 | RSU Vesting Compensation | 4.88K | — |
2/21/2023 | RSU Vesting Compensation | 3.27K | — |
| Total | 41.15K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
41.15K
Market value
$910.7K
3/2/2026
Total
Units
41.15K
Value
$910.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 41.15K | $910.7K | Nasdaq | Planned |
| Total | 41.15K | $910.7K | ||